From: Identification of TRPM2 as a prognostic factor correlated with immune infiltration in ovarian cancer
Description | Gene maker | Cor | p-value |
---|---|---|---|
CD8 + T cell | CD8A | 0.36 | 6.27E-13 |
CD8B | 0.00 | 9.49E-01 | |
T cell | CD3D | 0.29 | 1.87E-08 |
CD3E | 0.36 | 1.25E-12 | |
CD2 | 0.38 | 3.92E-14 | |
B ell | CD19 | 0.12 | 1.89E-02 |
CD79A | 0.13 | 1.43E-02 | |
Monocyte | CD86 | 0.56 | 9.87E-32 |
CD115 (CSF1R) | 0.61 | 8.69E-39 | |
TAM | CCL2 | 0.12 | 2.60E-02 |
CD68 | 0.35 | 4.81E-12 | |
IL10 | 0.21 | 6.60E-05 | |
M1 Macrophage | INOS (NOS2) | 0.01 | 9.18E-01 |
IRF5 | 0.42 | 4.61E-17 | |
COX2 (PTGS2) | 0.10 | 5.52E-02 | |
M2 Macrophage | CD163 | 0.51 | 1.00E-25 |
VSIG4 | 0.49 | 9.35E-24 | |
MS4A4A | 0.39 | 5.54E-15 | |
Neutrophils | CD66 b (CEACAM8) | -0.04 | 4.54E-01 |
CD11b (ITGAM) | 0.59 | 2.99E-36 | |
CCR7 | 0.26 | 4.46E-07 | |
Natural killer cell | KIR2DL1 | 0.16 | 2.48E-03 |
KIR2DL3 | 0.08 | 1.42E-01 | |
KIR2DL4 | 0.24 | 2.46E-06 | |
KIR3DL1 | 0.21 | 6.91E-05 | |
KIR3DL2 | 0.06 | 2.39E-01 | |
KIR3DL3 | 0.22 | 2.68E-05 | |
Dendritic cell | HLA- DPB1 | 0.35 | 3.13E-12 |
HLA- DQB1 | 0.30 | 5.18E-09 | |
HLA- DRA | 0.32 | 5.11E-10 | |
HLA- DPA1 | 0.39 | 7.36E-15 | |
BCDA-1 (CD1C) | 0.21 | 3.69E-05 | |
BDCA-4 (NRP1) | 0.24 | 3.14E-06 | |
CD11c (ITGAX) | 0.57 | 3.71E-33 | |
Th1 | T-bet (TBX21) | 0.44 | 5.87E-19 |
STAT4 | 0.25 | 1.60E-06 | |
STAT1 | 0.25 | 1.09E-06 | |
IFN-γ(IFNG) | 0.25 | 6.87E-07 | |
TNF-α (TNF) | 0.08 | 1.27E-01 | |
Th2 | GATA3 | 0.04 | 4.26E-01 |
STAT6 | 0.41 | 2.65E-16 | |
STAT5A | 0.45 | 6.23E-20 | |
IL-13 | 0.14 | 6.88E-03 | |
Tfh | BCL6 | 0.20 | 9.41E-05 |
IL-21 | 0.17 | 1.16E-03 | |
Th17 | STAT3 | 0.34 | 9.94E-12 |
IL17A | 0.02 | 7.09E-01 | |
Treg | FOXP3 | 0.42 | 5.26E-17 |
CCR8 | 0.07 | 1.80E-01 | |
STAT5B | 0.17 | 1.22E-03 | |
TGFβ (TGFB1) | 0.43 | 5.85E-18 | |
T cell exhaustion | PD1 (PDCD1) | 0.35 | 5.56E-12 |
CTLA4 | 0.29 | 1.22E-08 | |
LAG3 | 0.37 | 1.97E-13 | |
HAVCR2 | 0.58 | 2.39E-34 | |
GZMB | 0.19 | 2.33E-04 | |
TOX | -0.13 | 1.04E-02 | |
TIGIT | 0.33 | 7.26E-11 |